Home  /  Resource Library  /  R-CHOP vs DA-EPOCH-R for double-expressor lymphoma: A University of California Hematologic Malignancies Consortium retrospective analysis

R-CHOP vs DA-EPOCH-R for double-expressor lymphoma: A University of California Hematologic Malignancies Consortium retrospective analysis

Retrospective study examined chemoimmunotherapy regimens for treatment of double hit lymphomas.